Saturday 17 October 2026
Export OSUR’s income statement to Excel — free account
OraSure Technologies, Inc.
OSUR Healthcare Medical Instruments & Supplies
OraSure Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $115.0 million, down 38.1% from fiscal 2024. In the quarter to June 2026, revenue fell 1.93%, EPS grew 134.6%, free cash flow fell 1.40% and total debt fell 8.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
3.61
0.20
−5.25%
Follow OSUR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 11.50 | 0.00 | 0.00 | 0.00 | 29.74 | 34.35 | 36.40 | 25.11 |
Piotroski F-Score |
3 | 5 | 8 | 4 | 1 | 3 | 2 | 6 | 5 | 9 |
Altman Z-Score |
1.47 | 2.97 | 8.60 | 3.60 | 5.34 | 8.35 | 8.00 | 14.46 | 18.75 | 13.99 |
P/S ratio |
1.55 | 1.45 | 1.50 | 0.90 | 2.68 | 4.16 | 3.20 | 3.93 | 6.82 | 3.81 |
P/FCF ratio |
0.00 | 11.40 | 4.63 | 0.00 | 0.00 | 0.00 | 1,010.71 | 21.80 | 47.82 | 24.15 |
Altman Z″-Score (non-manufacturers) |
6.76 | 9.22 | 13.27 | 7.24 | 7.26 | 10.21 | 10.84 | 12.80 | 10.91 | 11.52 |
Beneish M-Score |
(2.73) | (2.76) | (3.69) | (1.59) | (2.28) | (2.65) | (2.26) | (2.77) | (1.47) | (2.48) |
P/Operating CF |
(19.77) | 2,465.20 | 14.68 | (19.28) | (48.93) | 197.97 | (478.97) | 49.97 | (516.59) | (839.96) |
P/B ratio |
0.52 | 0.65 | 1.41 | 0.95 | 1.64 | 1.79 | 1.61 | 2.52 | 4.41 | 2.63 |
Price to Tangible BV |
0.64 | 0.76 | 1.54 | 1.09 | 1.92 | 2.10 | 1.93 | 2.75 | 4.96 | 3.12 |
EV/Sales |
(0.19) | 0.01 | 0.78 | 0.61 | 2.03 | 2.95 | 2.20 | 3.07 | 5.89 | 2.87 |
EV/EBITDA |
0.35 | 0.00 | 5.91 | 0.00 | 317.55 | 120.28 | 13.11 | 15.98 | 21.23 | 14.18 |
EV/Operating CF |
0.44 | 0.04 | 2.24 | (5.02) | (13.41) | 87.20 | 34.71 | 14.25 | 34.92 | 14.96 |
EV/FCF |
0.40 | 0.04 | 2.42 | (2.13) | (5.68) | (24.27) | 694.46 | 17.02 | 41.28 | 18.17 |
Quick Ratio |
5.57 | 8.71 | 8.36 | 2.63 | 2.91 | 5.34 | 5.91 | 6.84 | 6.16 | 8.12 |
Current Ratio |
6.58 | 9.95 | 9.77 | 4.71 | 4.40 | 6.21 | 6.86 | 7.84 | 6.88 | 9.02 |
Net Debt/EBITDA |
3.22 | 15.40 | (5.41) | 16.11 | (101.13) | (49.53) | (5.97) | (4.49) | (3.37) | (4.66) |
Debt/Assets |
0.02% | 0.02% | 0.05% | 0.11% | 0.42% | 0.20% | 0.39% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.26 | 0.39 | 0.87 | 0.86 | 0.51 | 0.43 | 0.47 | 0.59 | 0.66 | 0.65 |
Operating CF/Net income |
0.71 | (1.40) | 2.64 | 2.76 | 1.54 | (0.39) | 0.59 | 1.92 | 0.91 | 1.25 |
Capex/Depreciation |
(0.41) | (0.35) | (0.49) | (4.17) | (4.13) | (3.08) | (1.27) | (0.98) | (0.71) | (0.77) |
| (18.30%) | (4.64%) | 13.50% | (4.60%) | (5.90%) | (4.23%) | 5.64% | 7.53% | 13.94% | 11.42% | |
| (15.57%) | (4.05%) | 11.58% | (3.79%) | (5.02%) | (3.71%) | 5.01% | 6.67% | 12.28% | 9.93% | |
ROIC |
(31.75%) | (12.37%) | 14.54% | (5.45%) | (2.77%) | (1.70%) | 7.64% | 14.01% | 24.61% | 19.52% |
Return on Tangible Assets |
(26.30%) | (5.65%) | 13.68% | (5.43%) | (7.55%) | (5.07%) | 7.50% | 9.46% | 14.66% | 12.39% |
Average Days of Receivables |
70.46 | 46.78 | 36.16 | 66.69 | 70.79 | 82.55 | 87.23 | 69.97 | 92.90 | 56.45 |
Research and Development Expense of Revenue |
36.97% | 14.02% | 8.32% | 9.35% | 14.62% | 18.07% | 12.70% | 8.94% | 8.00% | 7.61% |
Selling, General and Administrative Expense of Revenue |
64.16% | 41.54% | 23.31% | 30.31% | 40.69% | 44.91% | 43.44% | 37.93% | 34.63% | 45.25% |
Intangible Assets out of Total Assets |
0.15 | 0.12 | 0.08 | 0.11 | 0.12 | 0.13 | 0.15 | 0.08 | 0.10 | 0.14 |
Share Based Compensation of Revenue |
8.82% | 6.41% | 2.65% | 3.00% | 3.34% | 4.16% | 2.62% | 8.38% | 4.17% | 4.73% |
Graham Net Nets |
1.12 | 0.98 | 0.55 | 0.71 | 0.35 | 0.33 | 0.37 | 0.26 | 0.16 | 0.27 |
Graham Number |
0.00 | 0.00 | 9.75 | 0.00 | 0.00 | 0.00 | 5.50 | 5.96 | 7.22 | 5.13 |
Earnings Yield |
(38.43%) | (7.20%) | 8.70% | (5.43%) | (3.68%) | (2.22%) | 3.36% | 2.91% | 2.75% | 3.98% |
Free Cash Flow Yield |
(29.93%) | 8.77% | 21.62% | (31.96%) | (13.35%) | (2.92%) | 0.10% | 4.59% | 2.09% | 4.14% |
Revenue per Share |
1.57 | 2.50 | 5.53 | 5.34 | 3.25 | 2.54 | 2.51 | 2.97 | 2.83 | 2.31 |
Operating CF per Share |
(0.67) | 0.37 | 1.93 | (0.65) | (0.49) | 0.09 | 0.16 | 0.64 | 0.48 | 0.44 |
Capex per Share |
(0.06) | (0.05) | (0.14) | (0.88) | (0.67) | (0.43) | (0.15) | (0.10) | (0.07) | (0.08) |
Free Cash Flow per Share |
(0.72) | 0.32 | 1.79 | (1.53) | (1.16) | (0.34) | 0.01 | 0.54 | 0.40 | 0.36 |
Cash per Share |
2.71 | 3.60 | 3.96 | 1.53 | 2.13 | 3.10 | 2.53 | 2.56 | 2.64 | 2.17 |
Shareholders Equity per Share |
4.64 | 5.51 | 5.87 | 5.03 | 5.29 | 5.90 | 4.98 | 4.64 | 4.37 | 3.34 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.64 | 5.51 | 5.87 | 5.03 | 5.29 | 5.90 | 4.98 | 4.64 | 4.37 | 3.34 |
Free Cash Flow |
(53.22) | 23.58 | 131.28 | (110.99) | (83.50) | (23.12) | 0.49 | 32.75 | 23.82 | 20.25 |
Working Capital |
222.11 | 299.74 | 346.92 | 256.13 | 231.24 | 242.40 | 191.84 | 191.33 | 189.67 | 139.11 |
Capital Expenditures |
(4.20) | (3.80) | (10.30) | (63.79) | (48.12) | (28.92) | (9.31) | (6.34) | (4.34) | (4.35) |
Net Current Asset Value |
199.57 | 263.90 | 334.29 | 245.44 | 218.85 | 232.99 | 182.40 | 187.12 | 183.79 | 134.36 |
EV/EBIT |
0.30 | 0.00 | 9.70 | 0.00 | 0.00 | 0.00 | 18.28 | 19.60 | 24.43 | 18.15 |
Capex to Sales |
0.04 | 0.02 | 0.03 | 0.16 | 0.21 | 0.17 | 0.06 | 0.03 | 0.03 | 0.03 |
Price to Operating Income |
0.00 | 0.00 | 18.58 | 0.00 | 0.00 | 0.00 | 26.61 | 25.11 | 28.31 | 24.12 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.26 | 0.24 | 0.46 | 0.26 | 0.16 | 0.18 | 0.24 | 0.27 | 0.28 | 0.28 |
Cash ROIC |
(9.85%) | 3.48% | 18.20% | (23.33%) | (15.59%) | (3.80%) | 0.11% | 7.44% | 5.75% | 6.60% |
Accounts Receivable Turnover |
5.00 | 5.81 | 7.31 | 6.67 | 5.55 | 4.53 | 4.31 | 4.70 | 5.36 | 6.56 |
Accounts Payable Turnover |
9.10 | 9.98 | 9.14 | 7.24 | 5.11 | 5.18 | 5.95 | 6.54 | 9.17 | 8.27 |
Inventory Turnover |
2.05 | 2.60 | 3.26 | 3.21 | 2.73 | 2.54 | 2.61 | 3.23 | 4.37 | 3.21 |
Average Days of Payables |
35.62 | 28.03 | 20.53 | 58.05 | 88.12 | 90.96 | 58.18 | 56.78 | 54.81 | 42.10 |
Days of Inventory on Hand |
169.66 | 117.27 | 74.33 | 146.13 | 167.09 | 166.49 | 140.81 | 122.62 | 103.66 | 107.21 |
Average Receivables |
23.01 | 31.99 | 55.48 | 58.06 | 42.08 | 37.89 | 35.90 | 38.68 | 31.17 | 19.55 |
Average Payables |
7.35 | 10.66 | 25.59 | 33.02 | 22.72 | 13.49 | 10.08 | 10.41 | 7.43 | 4.86 |
Average Inventory |
32.63 | 40.91 | 71.66 | 74.42 | 42.50 | 27.51 | 23.02 | 21.12 | 15.57 | 12.52 |
Average Assets |
441.41 | 481.25 | 463.51 | 452.59 | 457.73 | 401.88 | 332.43 | 305.89 | 252.07 | 198.63 |
Average Common Equity |
375.58 | 420.50 | 397.55 | 372.48 | 389.55 | 352.86 | 295.26 | 270.73 | 221.97 | 172.64 |
Columns are period end dates